MicroRNAs associated with the pathogenesis of multiple sclerosis

Area of Science:

• Neuroimmunology
• Neurodegeneration
• Molecular Biology

Background:

• Multiple sclerosis (MS) is a complex autoimmune and neurodegenerative disease affecting the central nervous system.
• The precise mechanisms underlying MS pathogenesis remain incompletely understood.
• MicroRNAs (miRNAs) are increasingly recognized for their critical roles in disease processes.

Purpose of the Study:

• To review and discuss the alterations in miRNA expression observed in patients with multiple sclerosis.
• To explore the association between dysregulated miRNAs and the pathogenesis of MS.
• To evaluate the potential of miRNAs as biomarkers for MS diagnosis, treatment targets, and prognostic indicators.

Main Methods:

• Comprehensive literature review of studies investigating miRNA expression in multiple sclerosis patients.
• Analysis of reported associations between specific miRNA dysregulations and MS pathogenesis.
• Synthesis of evidence regarding the utility of miRNAs in MS diagnosis, therapy, and prognosis.

Main Results:

• Significant alterations in miRNA expression profiles have been detected in individuals with MS.
• Dysregulated miRNAs are demonstrably linked to key pathological pathways in multiple sclerosis.
• Evidence suggests miRNAs are involved in both autoimmune and neurodegenerative aspects of MS.

Conclusions:

• Altered miRNA expression is a hallmark of multiple sclerosis.
• Dysregulated miRNAs represent promising candidates for novel diagnostic biomarkers in MS.
• miRNAs hold potential as therapeutic targets and prognostic markers for guiding MS treatment strategies.